A rating of 84 puts GlycoMimetics Inc (GLYC) near the top of the Biotechnology industry according to InvestorsObserver. GlycoMimetics Inc's score of 84 means it scores higher than 84% of stocks in the industry. GlycoMimetics Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 113 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 51 would rank higher than 51 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With GlycoMimetics Inc Stock Today?
GlycoMimetics Inc (GLYC) stock is lower by -4.96% while the S&P 500 is up 1.13% as of 11:04 AM on Friday, May 14. GLYC is lower by -$0.12 from the previous closing price of $2.52 on volume of 724,615 shares. Over the past year the S&P 500 has risen 45.80% while GLYC is lower by -16.96%. GLYC lost -$1.22 per share the over the last 12 months.
Click Here to get the full Stock Score Report on GlycoMimetics Inc (GLYC) Stock.
